Filing Details
- Accession Number:
- 0001181431-15-007656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-29 19:59:44
- Reporting Period:
- 2015-05-28
- Filing Date:
- 2015-05-29
- Accepted Time:
- 2015-05-29 19:59:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604063 | David Michael Staffieri | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Coo, Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-28 | 35,000 | $41.51 | 43,215 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-28 | 17,282 | $84.06 | 25,933 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-05-28 | 9,050 | $84.07 | 16,833 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2015-05-28 | 35,000 | $0.00 | 35,000 | $41.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2014-03-29 | 2016-03-29 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of $84.0673. The range of prices for the sale of these shares was $84.05 - $84.11, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock Appreciation Rights granted on 3/29/2011, which vested 50% each on 3/29/2014 and 3/29/2015.
Billionaire Hedge Funds
